BRCA1 and BRCA2: 1994 and beyond

Narod, Steven A., Foulkes, William D.·2004·Nature Reviews Cancer
DOI 10.1038/nrc1431

Cited by (978)

Items 301–400 of 978

  1. Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population
    Maria A. Loizidou, Marios A. Cariolou, Susan L. Neuhausen, Robert F. Newbold, Evy Bashiardes, Yiola Marcou, Thalia Michael, Maria Daniel, Eleni Kakouri, Panayiotis Papadopoulos et al. · 2009 · Breast Cancer Research and Treatment
  2. Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancers
    Chongkui Sun, Fan Zhang, Tao Xiang, Qianming Chen, Tej K. Pandita, Yuping Huang, Mickey C.‐T. Hu, Qin Yang · 2014 · Oncotarget
  3. A Deletion at the MouseXistGene ExposesTrans-effects That Alter the Heterochromatin of the Inactive X Chromosome and the Replication Time and DNA Stability of Both X Chromosomes
    Silvia V. Diaz-Perez, David O. Ferguson, Chen Wang, Györgyi Csankovszki, Chengming Wang, Shih-Chang Tsai, Devkanya Dutta, Vanessa Pérez, SunMin Kim, C.D. Eller et al. · 2006 · Genetics
  4. Recruitment, Genetic Counseling, and BRCA Testing for Underserved Women at a Public Hospital
    Robin Lee, Mary Stanley Beattie, Beth Crawford, Julie S. Mak, Nicola Stewart, Miriam S. Komaromy, Laura J. Esserman, Lucille Shaw, Jane McLennan, Lori M. Strachowski et al. · 2005 · Genetic Testing
  5. Estrogen Receptor Status Could Modulate the Genomic Pattern in Familial and Sporadic Breast Cancer
    Lorenzo Melchor, Emiliano Honrado, Jia Huang, Sara Álvarez, Tara L. Naylor, María J. García, Ana Osório, David Blesa, Michael R. Stratton, Barbara L. Weber et al. · 2007 · Clinical Cancer Research
  6. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2genes
    Heather Hondow, Stephen B. Fox, Gillian Mitchell, Rodney John Scott, Victoria Beshay, Stephen Q. Wong, kConFab Investigators, Alexander Dobrovic · 2011 · BMC Cancer
  7. Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression
    Hitoshi Tsuda · 2009 · Breast Cancer
  8. BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan
    Munir Ahmad Abu-Helalah, Belal Azab, Rasmi Mubaidin, Dema Ali, Hanan D. Jafar, Hussam Ahmad Alshraideh, Nizar Drou, Abdalla Awidi · 2020 · Scientific Reports
  9. BRCA1: An Endocrine and Metabolic Regulator
    Haim Werner · 2022 · Frontiers in Endocrinology
  10. Genetic Counseling and Testing for Common Hereditary Breast Cancer Syndromes
    Dawn C. Allain · 2008 · Journal of Molecular Diagnostics
  11. Alteration of WWOX in human cancer, a clinical view
    Izabela Baryła, Ewa Styczeń-Binkowska, Andrzej Kazimierz Bednarek · 2015 · Experimental Biology and Medicine
  12. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene
    Ivana Tichá, Zdeněk Kleibl, Jana Stribrna, Jaroslav Kotlas, Martina Zimovjanová, Martin Matějů, Michal Zikán, Petr Pohlreich · 2010 · Breast Cancer Research and Treatment
  13. Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study
    Franca Podo, Filippo Santoro, Giovanni Di Leo, Siranoush Manoukian, Clelia de Giacomi, Stefano Corcione, Laura Cortesi, Luca Alessandro Carbonaro, Rubina Manuela Trimboli, A Cilotti et al. · 2015 · Clinical Cancer Research
  14. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba
    Rolando Camacho Rodríguez, Antonio Alejandro Esperon, Ramón Ropero, María Caridad Rubio, Ronald Rodriguez, Rosa M. Ortiz, Juan J. Lence Anta, Mario de los Rios, Deyanira Carnesolta, Maria C. del Olivera et al. · 2008 · Familial Cancer
  15. The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30
    Ophira Ginsburg, Mohammad Reza Akbari, Zeba Aziz, Robert Young, Henry T. Lynch, Parviz Ghadirian, André Robidoux, Julián Esteban Londoño Hernández, Gonzalo Vásquez, Magda Conceição Barbosa Gomes et al. · 2009 · Familial Cancer
  16. BRCA1andBRCA2Mutations in an Asian Clinic-based Population Detected Using a Comprehensive Strategy
    Peter Ang, Irene H. K. Lim, Tze-Chuen Lee, Jie-Ting Luo, Danny C.T. Ong, Puay Hoon Tan, Ann S. G. Lee · 2007 · Cancer Epidemiology Biomarkers & Prevention
  17. Loss of BRCA1 expression may predict shorter time-to-progression in metastatic breast cancer patients treated with taxanes.
    Junichi Kurebayashi, Yutaka Yamamoto, Masafumi Kurosumi, Sumiko Okubo, Tsunehisa Nomura, Katsuhiro Tanaka, Hiroshi Sonoo · 2006 · PubMed
  18. Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients
    Wenhui Cao, Xiaogan Wang, Lucien Frappart, Dominique Rigal, Zhao‐Qi Wang, Yan Shen, Wei‐Min Tong · 2007 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
  19. FANCJ Helicase Operates in the Fanconi Anemia DNA Repair Pathway and the Response to Replicational Stress
    Yuliang Wu, Robert M. Brosh · 2009 · Current Molecular Medicine
  20. Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland
    M. Wang, Bing Yu, Kim C. Westerlind, Robert Strange, Galam Khan, Dattatraya Hari Patil, K. Boeneman, Leena Hilakivi‐Clarke · 2008 · Breast Cancer Research and Treatment
  21. Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting
    Debra Morgan, Heather Sylvester, Frances Lee Lucas, Susan Miesfeldt · 2009 · Familial Cancer
  22. PARP Inhibitors for the Treatment and Prevention of Breast Cancer
    Shaveta Vinayak, James M. Ford · 2010 · Current Breast Cancer Reports
  23. Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early‐onset breast cancer in Cyprus
    Maria A. Loizidou, Yiola Marcou, Violetta Anastasiadou, Robert F. Newbold, Andreas Hadjisavvas, Kyriacos C. Kyriacou · 2007 · Clinical Genetics
  24. BRCA1 Protein and Nucleolin Colocalize in Breast Carcinoma Tissue and Cancer Cell Lines
    Natalie Tulchin, Monique Chambon, Gloria Juan, STEVEN H. DIKMAN, James A. Strauchen, Leonard Ornstein, Blasé Billack, Nicholas T. Woods, Álvaro N.A. Monteiro · 2010 · American Journal Of Pathology
  25. Genetics and the Young Woman with Breast Cancer
    James P. Evans, Cécile Skrzynia, Lisa R. Susswein, Megan Harlan · 2006 · Breast Disease
  26. Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study
    Helena Marieke Verkooijen, Pierre Olivier Chappuis, Elisabetta Rapiti, Georges Vlastos, G Fioretta, Séverine Sarp, A P Sappino, Hyma Schubert, Christine Bouchardy · 2005 · British Journal of Cancer
  27. Identification of two evolutionarily conserved and functional regulatory elements in intron 2 of the human BRCA1 gene
    S. L. Wardrop, Melissa A. Brown · 2005 · Genomics
  28. Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network
    Xiao Fan, Julia Wynn, Ning Shang, Cong Liu, Alexander Fedotov, Miranda L. G. Hallquist, Adam H. Buchanan, Marc S. Williams, Maureen E. Smith, Christin Hoell et al. · 2021 · JNCI Cancer Spectrum
  29. BRCA1 Contributes to Cell Cycle Arrest and Chemoresistance in Response to the Anticancer Agent Irofulven
    Timothy D. Wiltshire, Jamie Senft, Yutian Wang, Gregory W. Konat, Sharon L. Wenger, Eddie Reed, Weixin Wang · 2007 · Molecular Pharmacology
  30. Ubiquitination and Proteasome-Mediated Degradation of BRCA1 and BARD1 during Steroidogenesis in Human Ovarian Granulosa Cells
    Yunzhe Lu, Asma Amleh, Jianlong Sun, Xuan Shun Jin, Shaun D. McCullough, Richard J. Baer, Daming Ren, Rong Li, Yanfen Hu · 2006 · Molecular Endocrinology
  31. Pancreatic cancer: BRCA mutation and personalized treatment
    Guopei Luo, Lu Yu, Kaizhou Jin, Cheng He, Meng Guo, Zuqiang Liu, Jiang Long, Chen Liu, Quanxing Ni, Xianjun Yu · 2015 · Expert Review of Anticancer Therapy
  32. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel
    Olivia M. Moran, Dina Nikitina, Robert Royer, Aletta Poll, Kelly A. Metcalfe, Steven Alexander Narod, Mohammad Reza Akbari, Joanne Kotsopoulos · 2016 · Breast Cancer Research and Treatment
  33. Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention
    Tatsuyuki Chiyoda, Peter C. Hart, Mark A. Eckert, Stephanie M. McGregor, Ricardo R. Lastra, Ryuji Hamamoto, Yusuke Nakamura, S. Diane Yamada, Olufunmilayo Ibironke Olopade, Ernst R. Lengyel et al. · 2017 · Cancer Prevention Research
  34. Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies
    Masanori Kurihara, Tatsuo Mano, Yuko Saito, Shigeo Murayama, Tatsushi Toda, Atsushi Iwata · 2019 · Brain Sciences
  35. BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance
    Yingyi Kong, Shinya Akatsuka, Yashiro Motooka, Hao Zheng, Zhen Cheng, Yukihiro Shiraki, Tomoji Mashimo, Tatsuhiko Imaoka, Shinya Toyokuni · 2022 · Redox Biology
  36. Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression
    Yan‐Qiu Wang, Qin Yan, Jiarong Zhang, Shuangdi Li, Yixia Yang, Xiaoping Wan · 2012 · Journal of obstetrics and gynaecology research
  37. A Role for MRE11, NBS1, and Recombination Junctions in Replication and Stable Maintenance of EBV Episomes
    Jayaraju Dheekollu, Zhong Deng, Andreas Wiedmer, Matthew D. Weitzman, Paul M. Lieberman · 2007 · PLoS ONE
  38. Possible DNA Viral Factors of Human Breast Cancer
    Chun‐Ru Hsu, Tsong‐Ming Lu, Lengsu William Chin, Chi‐Chiang Yang · 2010 · Cancers
  39. Relationship between Epidemiologic Risk Factors and Hormone Receptor Expression in Ovarian Cancer: Results from the Nurses' Health Study
    Jonathan L. Hecht, Joanne Kotsopoulos, Susan E. Hankinson, Shelley S. Tworoger · 2009 · Cancer Epidemiology Biomarkers & Prevention
  40. Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis
    Mingming Liang, Yun Zhang, Chenyu Sun, Feras Kamel Rizeq, Min Min, Tingting Shi, Yehuan Sun · 2018 · Molecular Diagnosis & Therapy
  41. Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: Evidence that they exert tumoricidal effects via tumor tropism
    YI, BO-RIM, CHOI, KELVIN J., KIM, SEUNG U., CHOI, KYUNG-CHUL · 2012 · International Journal of Oncology
  42. Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?
    Steven Alexander Narod, Kelly A. Metcalfe, Henry T. Lynch, Parviz Ghadirian, André Robidoux, Nadine Tung, Elizabeth Mary Gaughan, Charmaine Kim‐Sing, Olufunmilayo Ibironke Olopade, William David Foulkes et al. · 2013 · Breast Cancer Research and Treatment
  43. Knowledge, attitudes, and clinical experience of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromes
    Amanda C. Brandt, Matthew L. Tschirgi, Kaylene J. Ready, Charlotte Sun, Sandra A. Darilek, Jacqueline T. Hecht, Banu Arun, Karen H. Lu · 2010 · Familial Cancer
  44. Loss of BRCA1 leads to an increased sensitivity to Bisphenol A
    Laundette P. Jones, Aishia Sampson, Hyo Jin Kang, Hee Jeong Kim, Yong Weon Yi, Sun Young Kwon, Janice K. Babus, Antai Wang, Insoo Bae · 2010 · Toxicology Letters
  45. TUSC4 functions as a tumor suppressor by regulating BRCA1's stability via the E3 ubiquitination pathway
    Yang Peng, H. Dai, E. Wang, Curtis Chun-Jen Lin, W. Mo, G. Peng, Shiaw-Yih Lin · 2014 · Cancer Research
  46. Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial
    Rena J. Pasick, Galen Joseph, SUSAN LEROY STEWART, Celia Patricia Kaplan, Robin Lee, Judith A. Luce, Sharon Watkins Davis, Titas Marquez, Tung Thanh Nguyen, Cláudia Guerra · 2016 · American Journal of Public Health
  47. Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR)
    Matthew S. Lebo, Kathleen-Rose Zakoor, Kathy Chun, Marsha D. Speevak, John S. Waye, Elizabeth McCready, Jillian S. Parboosingh, Ryan E. Lamont, Harriet E. Feilotter, Ian Bosdet et al. · 2017 · Genetics in Medicine
  48. Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
    Supriya Behl, Nancy Hamel, Manon de Ladurantaye, Stephanie E. Lepage, Réjean Lapointe, Anne‐Marie Mes‐Masson, William David Foulkes · 2020 · Scientific Reports
  49. RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination
    Xiaoting Wu, Yuhan Wang, Xiaoyue Cai, Yun Dong, Qing Cui, Ya-Ning Zhou, Xiwen Yang, Wenfeng Lu, Ming Zhang · 2021 · Cancer & Metabolism
  50. Computed cancer interactome explains the effects of somatic mutations in cancers
    Zhang, Jing, Pei, Jimin, Durham, Jesse, Bos, Tasia, Cong, Qian · 2022 · Protein Science
  51. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation
    Shouzhi Ma, Xiaohang Zhao · 2014 · Oncology Reports
  52. Breast cancer genetics in young women: What do we know?
    Liliana Gómez‐Flores‐Ramos, Rosa María Álvarez-Gómez, Cynthia Mayte Villarreal-Garza, Talía Wegman-Ostrosky, Alejandro Mohar · 2017 · Mutation Research/Reviews in Mutation Research
  53. CHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer
    Jupeng Yuan, Nasha Zhang, Hui Zhu, Jibing Liu, Huaixin Xing, Fei Ma, Ming Yang · 2017 · Scientific Reports
  54. An ELISA-based high throughput protein truncation test for inherited breast cancer
    Mark J. Lim, Gabriel Foster, Sadanand Gite, Heather P. Ostendorff, Steven Alexander Narod, Kenneth J. Rothschild · 2010 · Breast Cancer Research
  55. BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer
    Maja Sedic, Charlotte Kuperwasser · 2016 · Cell Cycle
  56. hsa-miR-212 modulates the radiosensitivity of glioma cells by targeting BRCA1
    Xin He, Saijun Fan · 2017 · Oncology Reports · Retracted
  57. Spectrum of Germline BRCA1 and BRCA2 Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome
    Cristina Santonocito, Roberta Rizza, Ida Paris, Laura De Marchis, Carmela Paolillo, Giordana Tiberi, Giovanni Scambia, Ettore Capoluongo · 2020 · Cancers
  58. A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers.
    Erica Rowan, Aletta Poll, Steven Alexander Narod · 2007 · Europe PMC (PubMed Central)
  59. Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer
    Anna L. Stratford, Kristen M. Reipas, Christopher A. Maxwell, Sandra Elaine Dunn · 2010 · Expert Reviews in Molecular Medicine
  60. Checking in on Hypoxia/Reoxygenation
    Rachel A. Freiberg, Adam J. Krieg, Amato J. Giaccia, Ester M. Hammond · 2006 · Cell Cycle
  61. ACCA Phosphopeptide Recognition by the BRCT Repeats of BRCA1
    Hind Ray, Karen Moreau, Éva Dizin, Isabelle Callebaut, Nicole Dalla Venezia · 2006 · Journal of Molecular Biology
  62. BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica
    GA Gutiérrez Espeleta, M. Llacuachaqui, L. Garcia Jimenez, M. A. Herrera, K. Vega, A. Ortiz, R. Royer, S. Li, S. Narod · 2012 · Clinical Genetics
  63. Increased BRCA1 protein in mammary tumours of rats fed marine ω-3 fatty acids
    Marie‐Lise Jourdan, Karine Mahéo, Aurélia Barascu, Caroline Goupille, Monique de Latour, Philippe Bougnoux, Pascale G. Rio · 2007 · Oncology Reports
  64. Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers
    Chiara Pepe, Lucia Guidugli, Elisa Sensi, Paolo Aretini, E D'Andrea, Marco Montagna, Siranoush Manoukian, Laura Ottini, Paolo Radice, Alessandra Viel et al. · 2006 · Breast Cancer Research and Treatment
  65. Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis
    Li-Na Zhou, Yue Tan, Ping Li, Ping Zeng, Min‐Bin Chen, Ye Tian, Yaqun Zhu · 2016 · Oncotarget
  66. Development and Pilot Evaluation of Novel Genetic Educational Materials Designed for an Underserved Patient Population
    Rebecca Lubitz, Miriam S. Komaromy, Beth Crawford, Mary Stanley Beattie, Robin Lee, Judith A. Luce, John L. Ziegler · 2007 · Genetic Testing
  67. ATM haplotypes and breast cancer risk in Jewish high-risk women
    M Koren, Gad Kimmel, Edna Ben‐Asher, I. G Gal, Moshe Zvi Papa, Jacques Samuel Beckmann, Doron Lancet, Ron Shamir A, Eitan Friedman · 2006 · British Journal of Cancer
  68. Effect of genome-wide association studies, direct-to-consumer genetic testing, and high-speed sequencing technologies on predictive genetic counselling for cancer risk
    Michael R. Speicher, Jochen B. Geigl, Ian P.M. Tomlinson · 2010 · The Lancet Oncology
  69. 'Omic approaches to preventing or managing metastatic breast cancer
    Obi L. Griffith, Joe W. Gray · 2011 · Breast Cancer Research
  70. AKT1 represses gene conversion induced by different genotoxic stresses and induces supernumerary centrosomes and aneuploidy in hamster ovary cells
    Isabelle Plo, Bernard S. López · 2009 · Oncogene
  71. Identification of BAF57 mutations in human breast cancer cell lines
    Evangelos Kiskinis, Juana Maria Garcia-Pedrero, M. Ángeles Villaronga, Malcolm G. Parker, Borja Belandia · 2006 · Breast Cancer Research and Treatment
  72. Characterization of Familial Non-BRCA1/2Breast Tumors by Loss of Heterozygosity and Immunophenotyping
    Rogier A. Oldenburg, Karin Kroeze‐Jansema, Hanne E.J. Meijers-Heijboer, Cristi J. van Asperen, Nicoline Hoogerbrugge, Inge van Leeuwen‐Cornelisse, Hans F. A. Vasen, Anne‐Marie Cleton-Jansen, Jaennelle Kraan, Jeanine J. Houwing‐Duistermaat et al. · 2006 · Clinical Cancer Research
  73. Prognostic Significance of CHEK2 Mutation in Progression of Breast Cancer
    Narges Ansari, Saeid Shahrabi, Abbas Khosravi, Reza Shirzad, Hadi Rezaeean · 2019 · Laboratory Medicine
  74. Synthetic lethality on drug discovery: an update on cancer therapy
    Mohammad Shahar Yar, Kashif Haider, Vivek Gohel, Nasir Ali Siddiqui, Ähmed Kamal · 2020 · Expert Opinion on Drug Discovery
  75. LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2
    Junsong Zhao, Junchao Xu, Mingming Wu, Wei Wang, Miaomiao Wang, Leiyan Yang, Huayong Cai, Qiao Xu, Ceshi Chen, Peter Edward Lobie et al. · 2023 · International Journal of Molecular Sciences
  76. A PP1-binding motif present in BRCA1 plays a role in its DNA repair function
    Young‐Mi Yu, Serena M. Pace, Susan R. Allen, Chu‐Xia Deng, Lih‐Ching Hsu · 2008 · International Journal of Biological Sciences
  77. RAP80 Is Critical in Maintaining Genomic Stability and Suppressing Tumor Development
    Zhengyu Yin, Daniel Menéndez, Michael A. Resnick, John Edgar French, Kyathanahalli S. Janardhan, Anton M. Jetten · 2012 · Cancer Research
  78. The role of BRCA1 and BRCA2 in prostate cancer
    Roy A. Jensen · 2013 · Frontiers in bioscience
  79. Lack of Germ-Line Promoter Methylation in BRCA1 -Negative Families with Familial Breast Cancer
    Ying Chen, Amanda Ewart Toland, Jane McLennan, Jane Fridlyand, Beth Crawford, J Costello, John L. Ziegler · 2006 · Genetic Testing
  80. Getting to the Root of BRCA1-Deficient Breast Cancer
    Christophe Ginestier, Suling Liu, Max S. Wicha · 2009 · Cell stem cell
  81. The identification of a novel role for BRCA1 in regulating RNA polymerase I transcription
    Rebecca Johnston, Zenobia D’Costa, Swagat Ray, Julia J. Gorski, Denis Paul Harkin, Paul B. Mullan, Kostya I. Panov · 2016 · Oncotarget
  82. Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
    Gabriel S. Macedo, Bárbara Alemar, Patrícia Ashton‐Prolla · 2019 · Genetics and Molecular Biology
  83. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer
    Li Zhang, Yinkui Wang, Zhongwu Li, Dongmei Lin, Yiqiang Liu, Linxin Zhou, Dongliang Wang, Aiwen Wu, Ziyu Li · 2021 · Diagnostic Pathology
  84. Cell Cycle Progression following Naive T Cell Activation Is Independent of Jak3/Common γ-Chain Cytokine Signals
    Min Shi, Tsung H. Lin, Kenneth C. Appell, Leslie J. Berg · 2009 · The Journal of Immunology
  85. Genetically Engineered Rat Models for Breast Cancer
    Bart M. G. Smits, Michelle S. Cotroneo, Jill D. Haag, Michael N. Gould · 2007 · Breast Disease
  86. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia
    M Konečný, Miriam Milly, Katarína Závodná, Eva Weismanova, Jaroslava Gregorova, Iveta Mlkva, Denisa Ilenčíková, J Kausitz, Zdena Bartošová · 2011 · Breast Cancer Research and Treatment
  87. Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis
    Alicia A. Tone, Carl Virtanen, Patricia H. Shaw, Theodore J. Brown · 2012 · Clinical Cancer Research
  88. Family history, BRCA mutations and breast cancer in Vietnamese women
    Ophira Ginsburg, NV Dinh, T.V. To, LH Quang, ND Linh, BTH Duong, R Royer, Marcia Llacuachaqui, Anna Tulman, G. Vichodez et al. · 2010 · Clinical Genetics
  89. CAG repeat size in Huntingtin alleles is associated with cancer prognosis
    for GEMO, Morgane Sonia Thion, Sophie Tézenas du Montcel, Jean‐Louis Golmard, Sophie Vacher, Laure Barjhoux, Valérie Sornin, Cécile Cazeneuve, Ivan Bièche, Olga M. Sinilnikova et al. · 2016 · European Journal of Human Genetics
  90. A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago
    Talia R. Donenberg, Humayun Ahmed, Robert Royer, Shiyu Zhang, Steven Alexander Narod, Sophia H.L. George, Mohammad Reza Akbari, Jameel Ali, Judith E. Hurley · 2016 · Breast Cancer Research and Treatment
  91. Expression of miR‑146a‑5p in breast cancer and its role in proliferation of breast cancer cells
    wei gao, Hua Jing, Jia Zhaoyang, Ding Ji-ping, Han Zengwei, Dong Yun, Lin Qing, Yao Zong YUAN · 2018 · Oncology Letters
  92. Numerous high-risk epithelial lesions in familial breast cancer
    Nicoline Hoogerbrugge, Peter Bult, Johannes J. Bonenkamp, Marjolijn J. L. Ligtenberg, Lambertus A.L.M. Kiemeney, Joanne A. de Hullu, Carla Boetes, Martinus F. Niermeijer, Han G. Brunner · 2006 · European Journal of Cancer
  93. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
    Maria Hietala, T. Sandberg, Åke Borg, Hakan Lars Olsson, Helena Jernström · 2006 · Human Reproduction
  94. Isolation and Molecular Characterization ofToxoplasma gondiiFrom Chickens From Sri Lanka
    Jitender Prakash Dubey, R.P.V.J. Rajapakse, Dilrukshi K. Ekanayake, Chirukandoth Sreekumar, Tovi Lehmann · 2005 · Journal of Parasitology
  95. BRCA1 in breast and ovarian cancer predisposition
    Blasé Billack, Álvaro N.A. Monteiro · 2004 · Cancer Letters
  96. Measuring DNA Repair Capacity: Small Steps
    Marianne Berwick, Paolo Vineis · 2005 · JNCI Journal of the National Cancer Institute
  97. Clonality analysis of synchronous gastro‐oesophageal junction carcinoma and distal gastric cancer by whole‐exome sequencing
    Xiaofang Xing, Shuqin Jia, Jianmin Wu, Qin Fu Feng, Bin Dong, Bo Li, Yongning Jia, Fei Shan, Ying'ai Li, Yan Zhang et al. · 2017 · The Journal of Pathology
  98. Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?
    Agostina Stradella, Jesús Del Valle, Paula Rofes, Lídia Feliubadaló, Èlia Grau Garces, Àngela Velasco, Sara González, Gardenia Vargas‐Parra, Á. Izquierdo, Olga Campos et al. · 2018 · Journal of Medical Genetics
  99. Glucose Concentration in Cell Culture Medium Influences the BRCA1-Mediated Regulation of the Lipogenic Action of IGF-I in Breast Cancer Cells
    Moses O. Koobotse, Dayane Schmidt, Jeff M.P. Holly, Claire M. Perks · 2020 · International Journal of Molecular Sciences
  100. Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer
    Xiaobo Ma, Yuanyuan Xu, Meng-Xuan Zhu, Lu Wang · 2021 · Frontiers in Oncology